Literature DB >> 15116061

Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia.

Eugenia L Siegler1, Marcus Reidenberg.   

Abstract

Clinicians often encounter patients with dementia and urge incontinence who might benefit from both an anticholinergic medication and a cholinesterase inhibitor. At first glance, this combination would seem to violate basic principles of geriatric pharmacology, as the drugs appear to be working at cross-purposes and anticholinergic medications are notorious for worsening cognitive function in susceptible patients. A case is presented and discussed in which this combination was clinically effective and pharmacologically sound.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15116061     DOI: 10.1016/j.clpt.2004.01.015

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Imidafenacin has no influence on learning in nucleus basalis of Meynert-lesioned rats.

Authors:  Takanobu Yamazaki; Ayako Fukata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-08-31       Impact factor: 3.000

Review 2.  Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.

Authors:  Dustin Pagoria; R Corey O'Connor; Michael L Guralnick
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

Review 3.  Antimuscarinic treatment in overactive bladder: special considerations in elderly patients.

Authors:  Adrian S Wagg
Journal:  Drugs Aging       Date:  2012-07-01       Impact factor: 3.923

Review 4.  Brain Over Bladder: A Systematic Review of Dual Cholinesterase Inhibitor and Urinary Anticholinergic Use.

Authors:  Laura K Triantafylidis; Jenna S Clemons; Emily P Peron; John Roefaro; Kristin M Zimmerman
Journal:  Drugs Aging       Date:  2018-01       Impact factor: 3.923

Review 5.  Managing Urinary Incontinence in Patients with Dementia: Pharmacological Treatment Options and Considerations.

Authors:  Susie Orme; Vikky Morris; William Gibson; Adrian Wagg
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

6.  Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.

Authors:  Kaycee M Sink; Joseph Thomas; Huiping Xu; Bruce Craig; Steven Kritchevsky; Laura P Sands
Journal:  J Am Geriatr Soc       Date:  2008-04-01       Impact factor: 5.562

Review 7.  Antimuscarinics for the treatment of overactive bladder: a review of central nervous system effects.

Authors:  Adam P Klausner; William D Steers
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 2.862

8.  Prescription rate of medications potentially contributing to lower urinary tract symptoms and detection of adverse reactions by prescription sequence symmetry analysis.

Authors:  Masako Hashimoto; Kanako Hashimoto; Fumihiko Ando; Yoshiaki Kimura; Keisuke Nagase; Kunizo Arai
Journal:  J Pharm Health Care Sci       Date:  2015-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.